Rapid two-dimensional Protein-A size exclusion chromatography of monoclonal antibodies for titer and aggregation measurements from harvested cell culture fluid samples
The success of monoclonal antibody (mAb) therapeutics have increased pharmaceutical investment in mAb production, which has led to a greater demand of technologies to efficiently characterize these biotherapeutics. The large size and heterogeneity of mAbs require the measurement of multiple critical...
Main Authors: | Zachary D. Dunn, Jayesh Desai, Gabriel M. Leme, Dwight R. Stoll, Douglas D. Richardson |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2019.1702263 |
Similar Items
-
The Past, the Present, and the Future of the Size Exclusion Chromatography in Extracellular Vesicles Separation
by: Hussein Kaddour, et al.
Published: (2021-11-01) -
A Novel approach to monoclonal antibody separation using high performance liquid affinity chromatography (HPLAC) with SelectiSpher-10 protein G /
by: Ohlson, Sten -
Quantitation of certolizumab pegol by validated liquid chromatography methods
by: Clóvis Dervil Appratto Cardoso Júnior, et al.
Published: (2023-11-01) -
Production of monoclonal antibodies from hybridomas by using ultroser HY asa culture medium and thier purification by liquid chromatography /
by: 318456 Sene, Claude, et al. -
Isolation and Quantification of Polystyrene Nanoplastics in Tissues by Low Pressure Size Exclusion Chromatography
by: François Gagné
Published: (2022-05-01)